Evidence map›Paper›PMID 35734711›Full record

ArticleAnnals of medicine and surgery (2012)2022

Prevalence of multidrug-resistant strains in device associated nosocomial infection and their in vitro killing by nanocomposites.

Shahbaz Aman, Divya Mittal, Shalini Shriwastav, Hardeep Singh Tuli, Shubham Chauhan, Pardeep Singh, Sheetal Sharma, Reena V Saini, Narinder Kaur, Adesh K Saini

Open access · diamondAbstract read
In one paragraph

Article in Annals of medicine and surgery (2012), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Evaluation ofCurrent drug delivery · 2025
    Article
  3. Article
  4. Article
  5. EnhancedCurrent medical mycology · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Intrinsic resistance: A non-negligible bacterial trait.Annals of medicine and surgery (2012) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Shahbaz AmanDepartment of Microbiology, MMIMSR, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, Haryana, 133207, India.
Divya MittalDepartment of Biotechnology, MMEC, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, Haryana, 133207, India.
Shalini ShriwastavDepartment of Microbiology, MMIMSR, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, Haryana, 133207, India.
Hardeep Singh TuliDepartment of Biotechnology, MMEC, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, Haryana, 133207, India.
Shubham ChauhanDepartment of Microbiology, MMIMSR, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, Haryana, 133207, India.
Pardeep SinghSchool of Advanced Chemical Sciences, Shoolini University, Solan, Himachal Pradesh, 173212, India.
Sheetal SharmaSchool of Advanced Chemical Sciences, Shoolini University, Solan, Himachal Pradesh, 173212, India.
Reena V SainiDepartment of Biotechnology, MMEC, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, Haryana, 133207, India.
Narinder KaurDepartment of Microbiology, MMIMSR, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, Haryana, 133207, India.
Adesh K SainiDepartment of Biotechnology, MMEC, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, Haryana, 133207, India.
Maharishi Markandeshwar University, Mullana · INShoolini University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: As per WHO, global burden of healthcare-associated infections (HAIs) ranges between 7% and 12%. There is a dire need to screen Device associated nosocomial infections (DANIs) in hospitals(1). To investigate the prevalence of microbes in hospitals in DANI cases and analyse in vitro control of multi-drug resistant strains by nanotechnology intervention. Methods: Patients diagnosed with DANI were enrolled and monitored. Identification and antibiotic susceptibility pattern of the etiological agent of DANIs were made by the phenotypic method and Vitek 2 automated systems according to standard protocol. In addition, biosynthesized nanocomposite was analysed for their antimicrobial activity by agar well-diffusion method, CFU count and DNA degradation analysis. Results: There were a total of 324 patients diagnosed with DANIs. Total 369 microbial pathogens were isolated from DANI patients. The majority (87%) of the pathogenic microbes were gram-negative bacilli and all were multidrug-resistant. 41.5% of the gram-negative isolates were ESBL producers. Methicillin-resistant Conclusions: DANI, which was found in patients of all age groups, us due to multidrug-resistant gram-negative bacteria. The most commn causative agents were

Indexed as

AntibacterialAntimicrobial-resistant, AMRCatheter-associated Urinary Tract Infection, CAUTICentral Line-associated Bloodstream Infection, CLABSIDevice associated nosocomial infectionDevice-associated Nosocomial Infections, DANIsHeathcare associated infectionsIntensive Care Unit, ICUMulti drug resistantNanocompositesVentilator-associated Pneumonia, VAP

Identifiers

PMID35734711
PMCPMC9207053
OpenAlexW4225402011

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.